Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian U Blank

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Current Opinion in Oncology|January 16, 2014
The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulationChristian U Blank
International Immunology|July 20, 2014
Therapeutic use of anti-CTLA-4 antibodiesChristian U Blank, Alexander Enk
Nature Reviews. Immunology|September 22, 2025
Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escapeFrancesca Fallarino, Christian U Blank
Nature Medicine|June 8, 2019
Combining checkpoint inhibition and targeted therapy in melanomaElisa A Rozeman, Christian U Blank
Immuno-Oncology Technology|June 27, 2022
A user's perspective on GeoMx<sup>TM</sup> digital spatial profilingTrieu My Van, Christian U Blank
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 19, 2020
Prognostic and predictive role of the tumor immune landscapeJohn B Haanen, Christian U Blank
Nature Medicine|April 11, 2020
Learning from clinical trials of neoadjuvant checkpoint blockadeJudith M Versluis, Georgina V Long, Christian U Blank
Journal for Immunotherapy of Cancer|August 27, 2020
Rationalizing the pathway to personalized neoadjuvant immunotherapy: the Lombard Street ApproachJudith M Versluis, Daniela S Thommen, Christian U Blank
Practical Neurology|March 15, 2013
Neurological immune-related adverse events of ipilimumabIlja Bot, Christian U Blank, Willem Boogerd, et al.
Cancer Immunology, Immunotherapy : CII|September 25, 2012
Mimicking homeostatic proliferation in vitro generates T cells with high anti-tumor function in non-lymphopenic hostsAndrew D Kaiser, Jules Gadiot, Aurelie Guislain, et al.
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Current Opinion in Oncology|January 16, 2014
The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulationChristian U Blank
International Immunology|July 20, 2014
Therapeutic use of anti-CTLA-4 antibodiesChristian U Blank, Alexander Enk
Nature Reviews. Immunology|September 22, 2025
Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escapeFrancesca Fallarino, Christian U Blank
Nature Medicine|June 8, 2019
Combining checkpoint inhibition and targeted therapy in melanomaElisa A Rozeman, Christian U Blank
Immuno-Oncology Technology|June 27, 2022
A user's perspective on GeoMx<sup>TM</sup> digital spatial profilingTrieu My Van, Christian U Blank
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 19, 2020
Prognostic and predictive role of the tumor immune landscapeJohn B Haanen, Christian U Blank
Nature Medicine|April 11, 2020
Learning from clinical trials of neoadjuvant checkpoint blockadeJudith M Versluis, Georgina V Long, Christian U Blank
Journal for Immunotherapy of Cancer|August 27, 2020
Rationalizing the pathway to personalized neoadjuvant immunotherapy: the Lombard Street ApproachJudith M Versluis, Daniela S Thommen, Christian U Blank
Practical Neurology|March 15, 2013
Neurological immune-related adverse events of ipilimumabIlja Bot, Christian U Blank, Willem Boogerd, et al.
Cancer Immunology, Immunotherapy : CII|September 25, 2012
Mimicking homeostatic proliferation in vitro generates T cells with high anti-tumor function in non-lymphopenic hostsAndrew D Kaiser, Jules Gadiot, Aurelie Guislain, et al.
Pageof 22